US

J. Michael Pearson

CEO of Valeant Pharmaceuticals; oversaw rapid roll-up growth and deceptive specialty pharmacy distribution channel, penalised by SEC.

INDIVIDUAL ENFORCEMENT RECORD
  • Name: J. Michael Pearson
  • Jurisdiction: US
  • Criminal Sentence: No prison sentence.
  • Officer & Director Bar: No statutory bar recorded.
  • Monetary Sanctions: Disclosed in docket narrative.
  • Case Records: Named in 1 primary fraud dossier(s).

PRIMARY ENFORCEMENT CASES INVOLVING J. MICHAEL PEARSON

PRIMARY SOURCE DOSSIERS
Case Title Jurisdiction Status Primary Scheme Role Outcome / Sanction
Valeant Pharmaceuticals: Undisclosed Captive Pharmacy Philidor and Channel Stuffing CA SETTLED channel stuffing OFFICER Used secret captive specialty pharmacy Philidor to prematurely recognize revenue and stuff distribution channels.

ROLE & CASE RECORD: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

FULL CASE DOSSIER →

Used secret captive specialty pharmacy Philidor to prematurely recognize revenue and stuff distribution channels.

The company manipulated its accounting records by executing schemes under channel-stuffing. Financial reports filed with market regulators contained material misstatements that distorted true financial condition.

Issuer: Valeant Pharmaceuticals International, Inc. • Primary Regulator: U.S. Securities and Exchange Commission • Action Date: September 20, 2017

Official Regulatory & Court Citations

  • [ENF-2015-valeant] Enforcement Action: Valeant Pharmaceuticals: Undisclosed Captive Pharmacy Philidor and Channel Stuffing (September 20, 2017): Used secret captive specialty pharmacy Philidor to prematurely recognize revenue and stuff distribution channels. Official Record ↗